Kerbert, AJC;
Verspaget, HW;
Navarro, ÀA;
Jalan, R;
Solà, E;
Benten, D;
Durand, F;
... CANONIC Study Investigators of the EASL-CLIF Consortium; + view all
(2017)
Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival.
Critical Care
, 21
, Article 321. 10.1186/s13054-017-1894-8.
Preview |
Text (Article)
Jalan_s13054-017-1894-8.pdf - Published Version Download (676kB) | Preview |
Preview |
Text (Table S1)
Jalan_13054_2017_1894_MOESM1_ESM.pdf Download (126kB) | Preview |
Preview |
Text (Table S2)
Jalan_13054_2017_1894_MOESM2_ESM.pdf Download (39kB) | Preview |
Preview |
Text (Table S3)
Jalan_13054_2017_1894_MOESM3_ESM.pdf Download (27kB) | Preview |
Preview |
Text (Table S4)
Jalan_13054_2017_1894_MOESM4_ESM.pdf Download (32kB) | Preview |
Preview |
Text (Table S5)
Jalan_13054_2017_1894_MOESM5_ESM.pdf Download (23kB) | Preview |
Preview |
Text (Table S6)
Jalan_13054_2017_1894_MOESM6_ESM.pdf Download (26kB) | Preview |
Preview |
Text (Table S7)
Jalan_13054_2017_1894_MOESM7_ESM.pdf Download (26kB) | Preview |
Preview |
Text (Table S8)
Jalan_13054_2017_1894_MOESM8_ESM.pdf Download (20kB) | Preview |
Abstract
BACKGROUND: Acute-on-chronic liver failure (ACLF) is characterized by the presence of acute decompensation (AD) of cirrhosis, organ failure, and high short-term mortality rates. Hemodynamic dysfunction and activation of endogenous vasoconstrictor systems are thought to contribute to the pathogenesis of ACLF. We explored whether copeptin, a surrogate marker of arginine vasopressin, is a potential marker of outcome in patients admitted for AD or ACLF and whether it might be of additional value to conventional prognostic scoring systems in these patients. METHODS: All 779 patients hospitalized for AD of cirrhosis from the CANONIC database with at least one serum sample available for copeptin measurement were included. Presence of ACLF was defined according to the CLIF-consortium organ failure (CLIF-C OF) score. Serum copeptin was measured in samples collected at days 0-2, 3-7, 8-14, 15-21, and 22-28 when available. Competing-risk regression analysis was applied to evaluate the impact of serum copeptin and laboratory and clinical data on short-term survival. RESULTS: Serum copeptin concentration was found to be significantly higher in patients with ACLF compared with those without ACLF at days 0-2 (33 (14-64) vs. 11 (4-26) pmol/L; p < 0.001). Serum copeptin at admission was shown to be a predictor of mortality independently of MELD and CLIF-C OF scores. Moreover, baseline serum copeptin was found to be predictive of ACLF development within 28 days of follow-up. CONCLUSIONS: ACLF is associated with significantly higher serum copeptin concentrations at hospital admission compared with those with traditional AD. Copeptin is independently associated with short-term survival and ACLF development in patients admitted for AD or ACLF.
| Type: | Article |
|---|---|
| Title: | Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1186/s13054-017-1894-8 |
| Publisher version: | http://dx.doi.org/10.1186/s13054-017-1894-8 |
| Language: | English |
| Additional information: | Copyright © The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| Keywords: | Acute-on-chronic liver failure, Biomarker, Cirrhosis, Copeptin, Organ failure |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inst for Liver and Digestive Hlth |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10040869 |
Archive Staff Only
 |
View Item |
